Related Experiment Video
Updated: Feb 5, 2026
07:25
Identification of Dopamine D1-Alpha Receptor Within Rodent Nucleus Accumbens by an Innovative RNA In Situ Detection Technology
Published on: March 27, 2018
9.0K
A dopamine D1 receptor agonist improved learning and memory in morphine-treated rats
Qiaofeng Liu1, Yanxia Li2, Yang Liu3
1a Department of Pathology and Pathophysiology , Basic Medical College, Chengdu Medical College , Chengdu , China.
Neurological Research
|September 18, 2018
Summary
Activating dopamine D1 receptors in the midbrain periaqueductal grey improves learning and memory in morphine-addicted rats by increasing GAD67 and reducing neuronal damage.
Area of Science:
- Neuroscience
- Pharmacology
Background:
- Morphine addiction significantly impairs learning and memory.
- The periaqueductal grey (PAG) plays a role in behavioral changes associated with addiction.
Purpose of the Study:
- To investigate the role of the dopamine (DA) D1 receptor in the PAG on learning and memory in morphine-addicted rats.
Main Methods:
- Administration of D1 receptor agonist (SKF81297) and antagonist (SCH23390) into the PAG.
- Assessment of learning and memory using the water maze task.
- Analysis of glutamate decarboxylase 67 (GAD67) and tyrosine receptor kinase B (TrkB) expression in the PAG via Western blot and immunohistochemistry.
Main Results:
- D1 receptor agonist administration improved learning and memory in morphine-addicted rats, evidenced by reduced latency to platform and increased platform crossings.
- Increased GAD67 expression and decreased TrkB expression were observed in the PAG following D1 receptor agonist treatment.
Conclusions:
- The PAG is implicated in the learning and memory deficits observed in morphine-addicted rats.
- Activation of DA D1 receptors in the PAG enhances learning and memory, potentially by increasing GAD67 and mitigating neuronal damage.
- While D1 receptor agonists reduced TrkB expression, its levels did not directly correlate with behavioral improvements.
Related Concept Videos
01:24Glucagon-like Receptor Agonists
978
Incretins include glucagon-like peptide-1 (GLP-1) and glucose-dependent insulinotropic polypeptide (GIP), which stimulate insulin secretion post-meals. In type 2 diabetes, GIP's efficacy is reduced, making GLP-1 a viable drug target. GIP originates from preproGIP.
GLP-1, when administered in high doses intravenously, triggers insulin secretion, inhibits glucagon release, slows gastric emptying, reduces food intake, and restores normal insulin secretion. However, its rapid inactivation by...
GLP-1, when administered in high doses intravenously, triggers insulin secretion, inhibits glucagon release, slows gastric emptying, reduces food intake, and restores normal insulin secretion. However, its rapid inactivation by...
978
01:25Drug-Receptor Interaction: Agonist
4.1K
Agonists are drugs that interact with specific receptors in the body to produce a biological response. When an agonist binds to a receptor, it activates or enhances the receptor's function, leading to physiological effects. The interaction between agonist drugs and receptors is crucial for their therapeutic action in various medical treatments.
Agonists can bind to receptors in different ways. Some agonists bind directly to the receptor's active site, mimicking the endogenous...
Agonists can bind to receptors in different ways. Some agonists bind directly to the receptor's active site, mimicking the endogenous...
4.1K
01:26Higher Mental Functions of Brain: Learning and Memory
2.1K
Memory is one of the most vital higher mental functions of the brain. Memory is closely related to learning because it enables us to retain information and experiences from our past to use them in our present life. It also helps us to remember facts, events, and skills, such as riding a bike or swimming. There are two types of memory — declarative memory, which involves memorizing facts or events, and procedural memory, which enables us to remember how to do something like writing or...
2.1K
01:23Drugs Affecting GI Tract Motility: Serotonin Receptor Agonists
992
Serotonin, a crucial neurotransmitter synthesized by enterochromaffin cells, plays a cardinal role in regulating gastrointestinal (GI) motility. With over 90% of the body's total serotonin in the GI tract, its influence on digestive processes is profound. Serotonin is swiftly released upon various stimuli, such as food boluses or certain drugs, triggering intrinsic sensory neurons in the myenteric plexus and extrinsic vagal and spinal sensory neurons. This leads to the activation of the...
992
01:28Drugs Affecting GI Tract Motility: Dopamine Receptor Antagonists
1.3K
Prokinetic agents are specialized medications that stimulate gastrointestinal (GI) motility, promoting food movement through the GI tract. Dopamine, an inhibitory neurotransmitter, plays a significant role in this process, reducing GI motility and indirectly controlling the speed of digestion. Dopamine receptor antagonists, such as metoclopramide and domperidone, offer a unique advantage as prokinetic agents. By blocking the dopamine receptors, these drugs increase GI motility, improving food...
1.3K
01:29Chemotherapy-Induced Nausea and Vomiting: Dopamine Receptor Antagonists
887
Dopamine receptor antagonists, also known as antipsychotic agents, are critical in managing chemotherapy-induced vomiting. These antiemetic agents block dopamine receptors in the chemoreceptor trigger zone (CTZ), inhibiting signal transmission to the vomiting center. Antipsychotic agents encompass phenothiazines (PTZ), butyrophenones, benzamides, and thienobenzodiazepines (Zyprexa), which are utilized for their antiemetic and sedative properties.
Phenothiazines, such as prochlorperazine...
Phenothiazines, such as prochlorperazine...
887